Grail acquisition by Illumina
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
acquisition
|
| gptkbp:acquiredBy |
gptkb:Grail
|
| gptkbp:acquirer |
gptkb:Illumina
|
| gptkbp:announced |
September 21, 2020
|
| gptkbp:completedIn |
August 18, 2021
|
| gptkbp:controversy |
antitrust concerns
|
| gptkbp:dealType |
cash and stock
|
| https://www.w3.org/2000/01/rdf-schema#label |
Grail acquisition by Illumina
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:purpose |
cancer detection technology
|
| gptkbp:regulatoryChallenge |
European Commission investigation
FTC lawsuit |
| gptkbp:regulatoryReview |
gptkb:European_Parliament
gptkb:US_Federal_Trade_Commission |
| gptkbp:result |
ordered divestiture by European Commission in 2023
|
| gptkbp:valuation |
$8 billion
|
| gptkbp:bfsParent |
gptkb:ARCH_Venture_Partners
|
| gptkbp:bfsLayer |
6
|